Skip to content

Correlation between duration of rocuronium and muscle mass.

Correlation between duration of rocuronium and muscle mass. - Correlation between duration of rocuronium and muscle mass.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000017884
Enrollment
60
Registered
2015-06-12
Start date
2015-07-20
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients undergoing elective surgery under general anesthesia in the supine position.

Interventions

None listed

Sponsors

Osaka Medical College
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients consented to participate in this study. ASA risk classification 1 and 2 and 3.

Exclusion criteria

Exclusion criteria: Emergency surgery cases, cases of heart failure, cases of neuromuscular disease, cases of local anesthetic use example of the limbs, anticonvulsants oral cases, renal dysfunction cases, severe hepatic dysfunction cases and pacemaker use cases are excluded.

Design outcomes

Primary

MeasureTime frame
Recovery time of T1 to 10% and 25% after single administration of rocuronium. mascle mass. lean body weight.

Countries

Japan

Contacts

Public ContactKazuo Hattori

Osaka Medical College Department of Anesthesiology

rsg39649@gmail.com072-683-1221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026